NVDA 2023 GTC - Before / During / AfterWith GTC 2024 approaching next week (starting 3/18/24) I did a look back to GTC 2023. There is obviously more hype going into this year's event (and different macro conditions), but may be useful to reflect.
This year Nvidia peaked near 975 on Friday 3/8 and fell sharply that very day. It's since recovered as of this writing to about 875.
Let's see how it all plays out this GTC and the weeks that follow.
Conference
EUR/USD prior the ECB Meeting definitely worth a deeper lookToday the ECB Meeting takes place. At 13:45 the Interest Rates will be announced here a cut is expected and already priced into the markets. At 14:30 it should get really interesting here Draghi will hold his last important speech at the ECB, it is expected that this speech will be very dovish kind of a farewell present from Draghi and we have seen that the markets definitely have priced in the outcome of this speech already, but could it actually be that that at this point of time too much has been priced in? We will see shortly....
EUR/USD and the Fed !New channel
The price has once again reached a key level on a weekly time frame: at the price of 1,127 a static support has formed, which tends to bounce the price and keeping it within this channel, with resistance at 1,146.
Very short, short and medium term
The trend remains bearish in the short term, while in the medium term it continues to be strongly bearish: with the macroeconomic scenarios that have been configured, the target area is between 1.10 and 1.08, despite this we believe that this week there may be a price rebound from this area because of the conference that will be held today by the president of FED Powell, who should still reassure the market, supporting the new very short-term monetary policy that will not lead to other restrictions.
Consequences
This should result in a sale on the US dollar by investors, devaluing the USD against the other majors, and therefore also against the euro (which remains highly unstable currency and will continue to depreciate for most of 2019).
Join us for further analysis on:
Instagram : www.instagram.com
Telegram: t.me
Facebook Page: www.facebook.com
Web: www.bfcminvest.com
EUR/USD and Mario Draghi ?! Ready to fall !The trend is bearish in the short and medium term, while in the very short it remains lateral. With the last conference of the ECB governor, the investors have been surprised by a sudden change of vision by Draghi, who said that as early as the first quarter of 2019 could start to issue money at 0 interest rate in favor of the banking system since the European economic situation is getting worse. Neither deposit rates and interest rates will be increased.
The main trend is now bearish in daily and weekly time frame, the price continues to move under the EMA 20 periods, and under the bearish ichimoku cloud, for the static level for a trend inversion (at 1.15) seems to be too strong to be passed in the short term, the price is rejected since the end of September.
The target, at this point, if Draghi confirmed the hypotheses declared in the conference on January 24th, would be in the support zone between 1.10 and 1.08.
IOP ConsolidationSo far IOP didn't make any big moves, we are consolidating the next 2 weeks should show us direction.
Don't forget about the Berlin conference on 16-17th of june. this should fuel iop rocket and send us in uptrend.
iop.global
This will be the last time to 8K for BTC?A possible bearish scenario for BTC could be a retracement around 8400-8300$
We are now sitting on a support visible on H4 timeline and another pullback could lead down to the next daily support at the price mentioned about, this match also the 0.5fib and the 200 SMA line is just above usually acting as a strong support.
On the daily timeline MACD is crossing, it's worth to keep an eye on it.
On the other hand If the price break over 9600$ I think this scenario will be considered invalid.
Now I think that there is another variable into the game that could drive the price a bit crazy: the 2018 Consensus conference!
It's on 14-16 may, this is one of the most awaited crypto summit of the year and could potentially influence the price in a positive way as happened in the 2017.
I'm just speculating but if the correction fall into the conference timeline how market will react? This will the last time we see price around 8K?
In any case the next days will be really interesting!
$CELZ Still Kicking Ass on the Way Up$CELZ Remains unstoppable into the Mid May Bio Conference where they will be presenting, DD below in links.
Ethereum MoonshotUsing a fractal of last time we hit this long term support, we should have a really nice bounce soon.
Ethereum has been getting plowed pretty hard and it's looking like it's time to flex again.
On April 15th there will also be a Dapp Dev Conference in Ukraine which should be a nice catalyst and raise confidence in investors showcasing future potential for Ethereum products.
RSI shows oversold too.
$CTRV 1st Conference Starts Tmrw Continues in the Right DrtnNothing entirely new to report. Closed above last major resistance and still continues to stair step in the right direction. I think it should be noted and I didn't mention it before but the corporations who took a stake in the company in the last two months:
Maxim Group set a $4.00 price target on shares of ContraVir Pharmaceuticals and gave the stock a “buy” rating in a research report on Tuesday, April 11th. Noble Financial reaffirmed a “Buy” rating on shares of ContraVir Pharmaceuticals in a research report on Friday, April 21st.
Teachers Advisors LLC boosted its position by 3.1% in the fourth quarter. Teachers Advisors LLC now owns 298,781 shares worth $1,820,000
Vanguard Group Inc. boosted its position in ContraVir Pharmaceuticals by 10.2% in the first quarter. Vanguard Group Inc. now owns 2,048,283 shares worth $3,626,000 after buying an additional 189,634 shares during the last quarter.
Geode Capital Management LLC boosted its position by 2.0% in the first quarter. Geode Capital Management LLC now owns 353,777 shares worth $626,000 after buying an additional 7,057 shares during the last quarter.
Morgan Stanley boosted its position in ContraVir Pharmaceuticals by 0.4% in the first quarter. Morgan Stanley now owns 278,798 shares worth $493,000 after buying an additional 1,119 shares during the last quarter.
5.49% of the stock is owned by institutional investors.
Very nice averages stakes taken by numerous groups and this is a month or two before the conferences. Shows some agencies might have gotten a sneak peak at the upcoming info. $CTRV
$CTRV Continues to trend upwards Amid Bio Conferences$CTRV announced today in addition to the 2017 Marcum MicroCap Conference 15-16 in New York, they will also be presenting at the San Diego Bio conference on June 19-22.
Let's think about this hypothetically. If there was no news to present or bad news they wouldn't have more than one conference, I mean one conference would be more than enough to tell everything in either of those two cases also who wants to put themselves through the embarrassment of a second conference if there wasn't something good down the line. Only time will tell but it is looking good in the right direction.
Also the techs are beyond bullish EMA / SMA crossover, PARSAR flip, resistance breaks support rebounds higher highs higher lows. All around very good.
pbs.twimg.com
MSTX on the eve of a pivotal Merger CC: CHART ANALYSYSMSTX (Mast therapeutics) shareholders have been overdue for some good news after the SEP data disaster wiped out nearly 80% of stock value dropping it from the .60s to a range of .10-15.
VAPOLAXOMER* was a novel technology designed by MSTX to help ease sufferers of sickle cell anemia that ultimately was proven ineffective and was abandoned.
Left with only AIR001, an inhaled sodium nitrite solution to treat heart failure with preserved ejection fraction (HFpEF) currently in Phase 2 development, MSTX had essentially become a shell with no substantial news until Q1'18.
Now MAST and SAVARA (a private company) have signed a DEFINITIVE MERGER AGREEMENT in effort to form a company focused on the development of novel inhalation therapies.
This reverse merger is essentially serving as an IPO for SAVARA and is likely to cause a nice pop in MSTX pps and a small P&D type move that could easily see pps of .33-57ish, potential gain % in the 200 which makes me a short term LONG but ultimately neutral.
Mast and Savara will hold the conference call TODAY Monday, January 9, 2017, at 8:30 a.m. EST / 5:30 a.m. PST to discuss the transaction. To access the conference call dial (855) 239-3120 from the U.S, (855) 669-9657 from Canada, and (412) 542-4127 from outside the U.S. and request the "Mast-Savara Conference Call". A live webcast of the conference call will be available from the Investors section of Mast's website at www.masttherapeutics.com
SIMPLE CHART ANALYSIS
SUP: backsliding is not likely to happen but if so look for a entry op @.0925-975
REALISTICALLY .095 should be the bounce point
RES: look for selling in the following zones WEAK @.107-12, MID @.13-15, STRONG @.17-26
REALISTICALLY .24 is the RES to look for
Notable RES:
W MBB @.1836/EMA50 @.2634
D EMAs .1175/17/25
-woof
SPY limit expousure and react quickly #SALT #TepperFrom SALT Conference in Las Vegas on Wednesday evening.
Tepper has one of the best long-term performance track records in the hedge fund world.
"I think we're OK. But, listen, there's times to make money and there's times not to lose money. This is probably you're supposed to think about preserving some of your money...I think you can still be long, but I think you're supposed to have some cash now."
"It's funny people think we're always bullish."
"I am nervous. I think it's nervous time."
He said the market is probably OK. "But it's getting dangerous."
"I'm not saying go short. Just don't go too friggin long."
Read more: www.businessinsider.com